發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

  ______   _    _   __    __     ___              
 /_____// | || | || \ \\ / //   / _ \\      ___   
 `____ `  | || | ||  \ \/ //   / //\ \\    /   || 
 /___//   | \\_/ ||   \  //   |  ___  ||  | [] || 
 `__ `     \____//     \//    |_||  |_||   \__ || 
 /_//       `---`       `     `-`   `-`     -|_|| 
 `-`                                         `-`